Regulation of RNA decay and cellular function by 3′-5′ exoribonuclease DIS3L2

References

• Astuti D, Morris MR, Cooper WN, et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet. 2012;44:277–284.
   PubMed Web of Science ®Google Scholar
• Lubas M, Damgaard CK, Tomecki R, et al. Exonuclease hDIS3L2 specifies an exosome-independent 3ʹ-5ʹ degradation pathway of human cytoplasmic mRNA. Embo J. 2013;32:1855–1868.
   PubMed Web of Science ®Google Scholar
• Ustianenko D, Hrossova D, Potesil D, et al. Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs. RNA. 2013;19:1632–1638.
   PubMed Web of Science ®Google Scholar
• Chang HM, Triboulet R, Thornton JE, et al. A role for the Perlman syndrome exonuclease DIS3L2 in the Lin28-let-7 pathway. Nature. 2013;497:244–248.
   PubMed Web of Science ®Google Scholar
• Malecki M, Viegas SC, Carneiro T, et al. The exoribonuclease DIS3L2 defines a novel eukaryotic RNA degradation pathway. Embo J. 2013;32:1842–1854.
   PubMed Web of Science ®Google Scholar
• Reimao-Pinto MM, Manzenreither RA, Burkard TR, et al. Molecular basis for cytoplasmic RNA surveillance by uridylation-triggered decay in Drosophila. Embo J. 2016;35:2417–2434.
   PubMed Web of Science ®Google Scholar
• Towler BP, Jones CI, Harper KL, et al. A novel role for the 3ʹ-5ʹ exoribonuclease DIS3L2 in controlling cell proliferation and tissue growth. RNA Biol. 2016;13:1286–1299.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Wen J, Bejarano F, et al. Characterization of a TUTase/RNase complex required for Drosophila gametogenesis. RNA. 2017;23:284–296.
   PubMed Web of Science ®Google Scholar
• Weaver BP, Zabinsky R, Weaver YM, et al. CED-3 caspase acts with miRNAs to regulate non-apoptotic gene expression dynamics for robust development in C. elegans. Elife. 2014;3:e04265.
   PubMed Web of Science ®Google Scholar
• Zhou X, Feng X, Mao H, et al. RdRP-synthesized antisense ribosomal siRNAs silence pre-rRNA via the nuclear RNAi pathway. Nat Struct Mol Biol. 2017;24:258–269.
   PubMed Web of Science ®Google Scholar
• Lebreton A, Tomecki R, Dziembowski A, et al. Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature. 2008;456:993–996.
   PubMed Web of Science ®Google Scholar
• Schaeffer D, Tsanova B, Barbas A, et al. The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities. Nat Struct Mol Biol. 2009;16:56–62.
   PubMed Web of Science ®Google Scholar
• Schneider C, Leung E, Brown J, et al. The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome. Nucleic Acids Res. 2009;37:1127–1140.
   PubMed Web of Science ®Google Scholar
• Faehnle CR, Walleshauser J, Joshua-Tor L. Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway. Nature. 2014;514:252–256.
   PubMed Web of Science ®Google Scholar
• Frazao C, McVey CE, Amblar M, et al. Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex. Nature. 2006;443:110–114.
   PubMed Web of Science ®Google Scholar
• Haas G, Cetin S, Messmer M, et al. Identification of factors involved in target RNA-directed microRNA degradation. Nucleic Acids Res. 2016;44:2873–2887.
   PubMed Web of Science ®Google Scholar
• Thomas MP, Liu X, Whangbo J, et al. Apoptosis triggers specific, rapid, and global mRNA decay with 3ʹ uridylated intermediates degraded by DIS3L2. Cell Rep. 2015;11:1079–1089.
   PubMed Web of Science ®Google Scholar
• Pirouz M, Du P, Munafo M, et al. DIS3L2-mediated decay is a quality control pathway for noncoding RNAs. Cell Rep. 2016;16:1861–1873.
   PubMed Web of Science ®Google Scholar
• Labno A, Warkocki Z, Kulinski T, et al. Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs. Nucleic Acids Res. 2016;44:10437–10453.
   PubMed Web of Science ®Google Scholar
• Ustianenko D, Pasulka J, Feketova Z, et al. TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. Embo J. 2016;35:2179–2191.
   PubMed Web of Science ®Google Scholar
• Nowak JS, Hobor F, Downie Ruiz Velasco A, et al. Lin28a uses distinct mechanisms of binding to RNA and affects miRNA levels positively and negatively. RNA. 2017;23:317–332.
   PubMed Web of Science ®Google Scholar
• Liu X, Fu R, Pan Y, et al. PNPT1 release from mitochondria during apoptosis triggers decay of Poly(A) RNAs. Cell. 2018;174:187–201 e12.
   PubMed Web of Science ®Google Scholar
• Wegert J, Ishaque N, Vardapour R, et al. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell. 2015;27:298–311.
   PubMed Web of Science ®Google Scholar
• Soma N, Higashimoto K, Imamura M, et al. Long term survival of a patient with Perlman syndrome due to novel compound heterozygous missense mutations in RNB domain of DIS3L2. Am J Med Genet A. 2017;173:1077–1081.
   PubMed Web of Science ®Google Scholar
• Higashimoto K, Maeda T, Okada J, et al. Homozygous deletion of DIS3L2 exon 9 due to non-allelic homologous recombination between LINE-1s in a Japanese patient with Perlman syndrome. Eur J Hum Genet. 2013;21:1316–1319.
   PubMed Web of Science ®Google Scholar
• Morris MR, Astuti D, Maher ER. Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2. Am J Med Genet C Semin Med Genet. 2013;163C:106–113.
   PubMed Web of Science ®Google Scholar
• Hunter RW, Liu Y, Manjunath H, et al. Loss of DIS3L2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells. Genes Dev. 2018;32:903–908.
   PubMed Web of Science ®Google Scholar
• Tassano E, Buttgereit J, Bader M, et al. Genotype-Phenotype correlation of 2q37 deletions including NPPC gene associated with skeletal malformations. PLoS One. 2013;8:e66048.
   PubMed Web of Science ®Google Scholar
• Reis FP, Pobre V, Silva IJ, et al. The RNase II/RNB family of exoribonucleases: putting the ‘Dis’ in disease. Wiley Interdiscip Rev RNA. 2013;4:607–615.
   PubMed Web of Science ®Google Scholar
• Pashler AL, Towler BP, Jones CI, et al. The roles of the exoribonucleases DIS3L2 and XRN1 in human disease. Biochem Soc Trans. 2016;44:1377–1384.
   PubMed Web of Science ®Google Scholar
• Mori F, Tanji K, Miki Y, et al. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease. Neurosci Lett. 2018;662:389–394.
   PubMed Web of Science ®Google Scholar
• Hagan JP, Piskounova E, Gregory RI. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol. 2009;16:1021–1025.
   PubMed Web of Science ®Google Scholar
• Heo I, Joo C, Kim YK, et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell. 2009;138:696–708.
   PubMed Web of Science ®Google Scholar
• Thornton JE, Chang HM, Piskounova E, et al. Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7). RNA. 2012;18:1875–1885.
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Katsura A, Miyazono K. A role of uridylation pathway for blockade of let-7 microRNA biogenesis by Lin28B. Cancer Sci. 2015;106:1174–1181.
   PubMed Web of Science ®Google Scholar
• de la Mata M, Gaidatzis D, Vitanescu M, et al. Potent degradation of neuronal miRNAs induced by highly complementary targets. EMBO Rep. 2015;16:500–511.
   PubMed Web of Science ®Google Scholar
• Heo I, Joo C, Cho J, et al. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell. 2008;32:276–284.
   PubMed Web of Science ®Google Scholar
• Nowak JS, Choudhury NR, de Lima Alves F, et al. Lin28a regulates neuronal differentiation and controls miR-9 production. Nat Commun. 2014;5:3687.
   PubMed Web of Science ®Google Scholar
• Hu W, Sweet TJ, Chamnongpol S, et al. Co-translational mRNA decay in Saccharomyces cerevisiae. Nature. 2009;461:225–229.
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Miyoshi K, Myers JR, et al. NMD-degradome sequencing reveals ribosome-bound intermediates with 3ʹ-end non-templated nucleotides. Nat Struct Mol Biol. 2018;25:940–950.
   PubMed Web of Science ®Google Scholar
• Standart N, Weil D. P-bodies: cytosolic droplets for coordinated mRNA storage. Trends Genet. 2018;34:612–626.
   PubMed Web of Science ®Google Scholar
• Pena-Blanco A, Garcia-Saez AJ. Bax, Bak and beyond - mitochondrial performance in apoptosis. FEBS J. 2018;285:416–431.
   PubMed Web of Science ®Google Scholar
• Jacobson MR, Cao LG, Wang YL, et al. Dynamic localization of RNase MRP RNA in the nucleolus observed by fluorescent RNA cytochemistry in living cells. J Cell Biol. 1995;131:1649–1658.
   PubMed Web of Science ®Google Scholar
• Matera AG, Wang Z. A day in the life of the spliceosome. Nat Rev Mol Cell Biol. 2014;15:108–121.
   PubMed Web of Science ®Google Scholar
• Guiro J, Murphy S. Regulation of expression of human RNA polymerase II-transcribed snRNA genes. Open Biol. 2017;7.
   PubMed Web of Science ®Google Scholar
• Reuter LM, Meinel DM, Strasser K. The poly(A)-binding protein Nab2 functions in RNA polymerase III transcription. Genes Dev. 2015;29:1565–1575.
   PubMed Web of Science ®Google Scholar
• Chang X, Li B, Rao A. RNA-binding protein hnRNPLL regulates mRNA splicing and stability during B-cell to plasma-cell differentiation. Proc Natl Acad Sci USA. 2015;112:E1888–1897.
   PubMed Web of Science ®Google Scholar
• Maatz H, Jens M, Liss M, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest. 2014;124:3419–3430.
   PubMed Web of Science ®Google Scholar
• Zhang P, Abdelmohsen K, Liu Y, et al. Novel RNA- and FMRP-binding protein TRF2-S regulates axonal mRNA transport and presynaptic plasticity. Nat Commun. 2015;6:8888.
   PubMed Web of Science ®Google Scholar
• Wang J, Rajbhandari P, Damianov A, et al. RNA-binding protein PSPC1 promotes the differentiation-dependent nuclear export of adipocyte RNAs. J Clin Invest. 2017;127:987–1004.
   PubMed Web of Science ®Google Scholar
• Zhou XJ, Wu J, Shi L, et al. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer. J Exp Clin Cancer Res. 2017;36:149.
   PubMed Web of Science ®Google Scholar
• Hou P, Li L, Chen F, et al. PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer. Cancer Res. 2018;78:387–398.
   PubMed Web of Science ®Google Scholar
• Roilo M, Kullmann MK, Hengst L. Cold-inducible RNA-binding protein (CIRP) induces translation of the cell-cycle inhibitor p27Kip1. Nucleic Acids Res. 2018;46:3198–3210.
   PubMed Web of Science ®Google Scholar
• Andrade JM, Dos Santos RF, Chelysheva I, et al. The RNA-binding protein Hfq is important for ribosome biogenesis and affects translation fidelity. Embo J. 2018;37.
   PubMed Web of Science ®Google Scholar
• Luo J, Liu H, Luan S, et al. Aberrant regulation of mRNA m(6)A modification in cancer development. Int J Mol Sci. 2018;19.
   Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93–95.
   PubMed Web of Science ®Google Scholar
• Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18–29.
   PubMed Web of Science ®Google Scholar
• Trippe R, Sandrock B, Benecke BJ. A highly specific terminal uridylyl transferase modifies the 3ʹ-end of U6 small nuclear RNA. Nucleic Acids Res. 1998;26:3119–3126.
   PubMed Web of Science ®Google Scholar
• Trippe R, Guschina E, Hossbach M, et al. Identification, cloning, and functional analysis of the human U6 snRNA-specific terminal uridylyl transferase. RNA. 2006;12:1494–1504.
   PubMed Web of Science ®Google Scholar
• Aphasizhev R, Aphasizheva I, Simpson L. A tale of two TUTases. Proc Natl Acad Sci USA. 2003;100:10617–10622.
   PubMed Web of Science ®Google Scholar
• Aphasizheva I, Maslov D, Wang X, et al. Pentatricopeptide repeat proteins stimulate mRNA adenylation/uridylation to activate mitochondrial translation in trypanosomes. Mol Cell. 2011;42:106–117.
   PubMed Web of Science ®Google Scholar
• Liu W, Yu Q, Ma J, et al. Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2. Onco Targets Ther. 2017;10:2367–2376.
   PubMed Web of Science ®Google Scholar
• Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94:1313–1326.
   PubMed Web of Science ®Google Scholar
• Abbastabar M, Kheyrollah M, Azizian K, et al. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein. DNA Repair (Amst). 2018;69:63–72.
   PubMed Web of Science ®Google Scholar
• El-Deiry WS. p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res. 2016;76:5189–5191.
   PubMed Web of Science ®Google Scholar
• Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer. 2013;13:727–738.
   PubMed Web of Science ®Google Scholar
• Jiang S, Baltimore D. RNA-binding protein Lin28 in cancer and immunity. Cancer Lett. 2016;375:108–113.
   PubMed Web of Science ®Google Scholar
• Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol. 2012;22:474–482.
   PubMed Web of Science ®Google Scholar
• Balzeau J, Menezes MR, Cao S, et al. The LIN28/let-7 pathway in cancer. Front Genet. 2017;8:31.
   PubMed Web of Science ®Google Scholar
• Barretina J, Caponigro G, Stransky N, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–607.
   PubMed Web of Science ®Google Scholar
• Eckwahl MJ, Sim S, Smith D, et al. A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathway. Genes Dev. 2015;29:646–657.
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27–47.
   PubMed Web of Science ®Google Scholar
• Liu X, Xiao ZD, Han L, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol. 2016;18:431–442.
   PubMed Web of Science ®Google Scholar
• Xiao ZD, Han L, Lee H, et al. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat Commun. 2017;8(1):783.
   PubMedGoogle Scholar
• Khan MR, Xiang S, Song Z, et al. The p53-inducible long noncoding RNA TRINGS pro0tects cancer cells from necrosis under glucose starvation. Embo J. 2017;36:3483–3500.
   PubMed Web of Science ®Google Scholar
• Chen J, OuYang H, An X, et al. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6. PLoS One. 2018;13:e0191325.
   PubMed Web of Science ®Google Scholar
• Tolkach Y, Niehoff EM, Stahl AF, et al. YRNA expression in prostate cancer patients: diagnostic and prognostic implications. World J Urol. 2018;36:1073–1078.
   PubMed Web of Science ®Google Scholar